- Home
- SCWO vs IXHL Comparison
SCWO vs IXHL Comparison
Compare SCWO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- IXHL
- Stock Information
- Founded
- SCWO 2021
- IXHL 2001
- Country
- SCWO United States
- IXHL Australia
- Employees
- SCWO N/A
- IXHL N/A
- Industry
- SCWO Environmental Services
- IXHL
- Sector
- SCWO Utilities
- IXHL
- Exchange
- SCWO Nasdaq
- IXHL Nasdaq
- Market Cap
- SCWO 58.8M
- IXHL 54.5M
- IPO Year
- SCWO N/A
- IXHL N/A
- Fundamental
- Price
- SCWO $0.35
- IXHL $0.53
- Analyst Decision
- SCWO
- IXHL
- Analyst Count
- SCWO 0
- IXHL 0
- Target Price
- SCWO N/A
- IXHL N/A
- AVG Volume (30 Days)
- SCWO 1.1M
- IXHL 114.7M
- Earning Date
- SCWO 11-12-2025
- IXHL 11-13-2025
- Dividend Yield
- SCWO N/A
- IXHL N/A
- EPS Growth
- SCWO N/A
- IXHL N/A
- EPS
- SCWO N/A
- IXHL N/A
- Revenue
- SCWO $1,231,413.00
- IXHL $98,000.00
- Revenue This Year
- SCWO $5,945.19
- IXHL $2,538.49
- Revenue Next Year
- SCWO $106.82
- IXHL $249.95
- P/E Ratio
- SCWO N/A
- IXHL N/A
- Revenue Growth
- SCWO 403.17
- IXHL N/A
- 52 Week Low
- SCWO $0.16
- IXHL $0.08
- 52 Week High
- SCWO $1.95
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- SCWO 55.11
- IXHL 48.14
- Support Level
- SCWO $0.37
- IXHL $0.50
- Resistance Level
- SCWO $0.41
- IXHL $0.59
- Average True Range (ATR)
- SCWO 0.05
- IXHL 0.08
- MACD
- SCWO 0.00
- IXHL -0.01
- Stochastic Oscillator
- SCWO 52.94
- IXHL 5.97
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.